Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Hepatitis C virus infection of human thyrocytes: metabolic, hormonal, and immunological implications.

Hammerstad SS, Blackard JT, Lombardi A, Owen RP, Concepcion E, Yi Z, Zhang W, Tomer Y.

J Clin Endocrinol Metab. 2019 Nov 30. pii: dgz241. doi: 10.1210/clinem/dgz241. [Epub ahead of print]

PMID:
31784757
2.

CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro.

Blackard JT, Kong L, Rouster SD, Karns R, Horn PS, Kottilil S, Shata MT, Sherman KE.

PLoS One. 2019 Oct 29;14(10):e0224523. doi: 10.1371/journal.pone.0224523. eCollection 2019.

3.

Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study.

Bhebhe L, Anderson M, Souda S, Choga WT, Zumbika E, Shaver ZM, Mbangiwa T, Phinius BB, Banda CC, Melamu P, Musonda RM, Essex M, Blackard JT, Moyo S, Gaseitsiwe S.

BMC Infect Dis. 2019 Oct 22;19(1):875. doi: 10.1186/s12879-019-4514-1.

4.

In response to identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients.

Blackard JT, Kwara A, Sherman KE.

J Hepatol. 2019 Dec;71(6):1259-1260. doi: 10.1016/j.jhep.2019.07.010. Epub 2019 Sep 26. No abstract available.

PMID:
31564447
5.

Identification of hepatitis B virus genotype A/E recombinants in Ghana.

Boyce CL, Willis S, Archampong TNA, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Kwara A, Blackard JT.

Virus Genes. 2019 Oct;55(5):707-712. doi: 10.1007/s11262-019-01690-y. Epub 2019 Jul 25.

PMID:
31346975
6.

Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis.

Baxter C, Ngcapu S, Blackard JT, Powell EA, Penton PK, Abdool Karim SS.

Viruses. 2019 Jun 19;11(6). pii: E569. doi: 10.3390/v11060569.

7.

Synthetic Opioid Use and Common Injection-associated Viruses: Expanding the Translational Research Agenda.

Blackard JT, Brown JL, Lyons MS.

Curr HIV Res. 2019;17(2):94-101. doi: 10.2174/1570162X17666190618154534.

8.

Tips for a Successful Global Health Sabbatical.

Blackard JT.

Ann Glob Health. 2019 May 9;85(1). pii: 66. doi: 10.5334/aogh.724.

9.

Zika virus replication and cytopathic effects in liver cells.

Sherman KE, Rouster SD, Kong LX, Aliota MT, Blackard JT, Dean GE.

PLoS One. 2019 Mar 20;14(3):e0214016. doi: 10.1371/journal.pone.0214016. eCollection 2019.

10.

Molecular characterization of hepatitis B virus in blood donors in Botswana.

Choga WT, Anderson M, Zumbika E, Moyo S, Mbangiwa T, Phinius BB, Melamu P, Kayembe MK, Kasvosve I, Sebunya TK, Blackard JT, Essex M, Musonda RM, Gaseitsiwe S.

Virus Genes. 2019 Feb;55(1):33-42. doi: 10.1007/s11262-018-1610-z. Epub 2018 Oct 31.

PMID:
30382563
11.

Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade.

Sherman KE, Abdel-Hameed E, Rouster SD, Shata MTM, Blackard JT, Safaie P, Kroner B, Preiss L, Horn PS, Kottilil S.

Clin Infect Dis. 2019 May 17;68(11):1911-1918. doi: 10.1093/cid/ciy807.

12.

In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm.

Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Makhema J, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S.

Genes (Basel). 2018 Aug 21;9(9). pii: E420. doi: 10.3390/genes9090420.

13.

Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana.

Mbangiwa T, Kasvosve I, Anderson M, Thami PK, Choga WT, Needleman A, Phinius BB, Moyo S, Leteane M, Leidner J, Blackard JT, Mayondi G, Kammerer B, Musonda RM, Essex M, Lockman S, Gaseitsiwe S.

Genes (Basel). 2018 May 17;9(5). pii: E259. doi: 10.3390/genes9050259.

14.

Zika Virus Exposure in an HIV-Infected Cohort in Ghana.

Sherman KE, Rouster SD, Kong LX, Shata TM, Archampong T, Kwara A, Aliota MT, Blackard JT.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):e35-e38. doi: 10.1097/QAI.0000000000001718. No abstract available.

15.

Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).

Blackard JT, Sherman KE.

Rev Med Virol. 2018 Jul;28(4):e1984. doi: 10.1002/rmv.1984. Epub 2018 May 15. Review.

16.

Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV).

N'Guessan KF, Boyce C, Kwara A, Archampong TNA, Lartey M, Sagoe KW, Kenu E, Obo-Akwa A, Blackard JT.

Virus Genes. 2018 Jun;54(3):361-367. doi: 10.1007/s11262-018-1555-2. Epub 2018 Mar 17.

17.

Molecular characterization of hepatitis B virus X gene in HIV-positive South Africans.

Gededzha MP, Sondlane TH, Malinga LA, Burnett RJ, Lebelo RL, Blackard JT, Mphahlele MJ, Selabe SG.

Virus Genes. 2018 Apr;54(2):190-198. doi: 10.1007/s11262-018-1536-5. Epub 2018 Feb 6.

PMID:
29411271
18.

A preliminary analysis of hepatitis C virus in pancreatic islet cells.

Blackard JT, Kong L, Lombardi A, Homann D, Hammerstad SS, Tomer Y.

Virol J. 2017 Dec 20;14(1):237. doi: 10.1186/s12985-017-0905-3.

19.

The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana.

N'Guessan KF, Anderson M, Phinius B, Moyo S, Malick A, Mbangiwa T, Choga WT, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT.

Open Forum Infect Dis. 2017 Oct 10;4(4):ofx222. doi: 10.1093/ofid/ofx222. eCollection 2017 Fall.

20.

Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.

Bari K, Luckett K, Kaiser T, Diwan T, Cuffy M, Schoech MR, Safdar K, Blackard JT, Apewokin S, Paterno F, Sherman KE, Zucker SD, Anwar N, Shah SA.

Hepatology. 2018 May;67(5):1673-1682. doi: 10.1002/hep.29704. Epub 2018 Mar 26.

PMID:
29205441

Supplemental Content

Loading ...
Support Center